Whalen Wealth Management Inc. purchased a new stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,661 shares of the company’s stock, valued at approximately $271,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Cherry Creek Investment Advisors Inc. boosted its position in shares of Zoetis by 2.0% in the 3rd quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company’s stock worth $590,000 after purchasing an additional 58 shares in the last quarter. Grove Bank & Trust boosted its holdings in Zoetis by 0.5% in the third quarter. Grove Bank & Trust now owns 11,763 shares of the company’s stock worth $2,298,000 after acquiring an additional 61 shares in the last quarter. Hancock Whitney Corp grew its stake in shares of Zoetis by 0.3% in the third quarter. Hancock Whitney Corp now owns 18,569 shares of the company’s stock worth $3,628,000 after acquiring an additional 61 shares during the last quarter. Strategy Asset Managers LLC increased its holdings in shares of Zoetis by 3.5% during the third quarter. Strategy Asset Managers LLC now owns 1,822 shares of the company’s stock valued at $356,000 after acquiring an additional 62 shares in the last quarter. Finally, Procyon Advisors LLC raised its position in shares of Zoetis by 1.4% in the 4th quarter. Procyon Advisors LLC now owns 4,712 shares of the company’s stock worth $768,000 after purchasing an additional 63 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.
Zoetis Stock Down 0.5 %
Zoetis stock opened at $166.64 on Thursday. The stock has a market cap of $75.18 billion, a PE ratio of 31.32, a price-to-earnings-growth ratio of 2.58 and a beta of 0.89. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. The stock has a fifty day moving average of $170.39 and a 200 day moving average of $179.80. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53.
Zoetis Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This is an increase from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.20%. Zoetis’s payout ratio is presently 37.59%.
Analyst Ratings Changes
Several brokerages recently commented on ZTS. Stifel Nicolaus cut their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. raised their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Leerink Partners started coverage on Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective on the stock. UBS Group started coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price for the company. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $211.89.
Read Our Latest Stock Analysis on Zoetis
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Further Reading
- Five stocks we like better than Zoetis
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- GitLab: AI-Driven DevSecOps Innovation Sets It Apart
- 10 Best Airline Stocks to Buy
- DigitalOcean’s AI Potential: A Game-Changer for Growth
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Supercharge Your Portfolio With These 3 Key Stocks
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.